Molecular Partners AG
SIX:MOLN
Molecular Partners AG
SIX:MOLN
Price:
3.17 CHF
-5.37%
Market Closed
Updated:
May 8, 2024
Molecular Partners AG
Net Income (Common)
|
Molecular Partners AG
Net Income (Common) Peer Comparison
Comparables:
ADCT
CRSP
BSLN
IDIA
KURN
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Molecular Partners AG
SIX:MOLN
|
Net Income (Common)
-CHf62m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
|
ADC Therapeutics SA
NYSE:ADCT
|
Net Income (Common)
-$240.1m
|
CAGR 3-Years
1%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Net Income (Common)
-$153.6m
|
CAGR 3-Years
24%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Net Income (Common)
CHf10.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Idorsia Ltd
SIX:IDIA
|
Net Income (Common)
-CHf827.9m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-125%
|
CAGR 10-Years
N/A
|
|
|
Kuros Biosciences AG
SIX:KURN
|
Net Income (Common)
-CHf13.7m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
See Also
What is Molecular Partners AG's Net Income (Common)?
Net Income (Common)
-62m
CHF
-62m
CHF
Based on the financial report for Dec 31, 2023, Molecular Partners AG's Net Income (Common) amounts to -62m CHF.
What is Molecular Partners AG's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
-11%
-11%
You don't have any saved screeners yet
